Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for prevention of established pulmonary hypertension in high-risk fibrotic lung disease
2007-001645-17Phase 4Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) comparing Tracleer with Placebo (2 arms). Started Oct 2007; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2007-001645-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001645-17.